Fundus of patient with teinitis pigmentosa. © By Christian Hamel - wikimedia.org

AI specialist WhiteLab Genomics, the Vision Institute, and IT expert ADLIN Science, have entered into a strategic partnership aimed at developing new AAV vectors targetting retinal dystrophies.

© University of Southern Denmark

A German-Danish team has discovered that a truncated version of the enzyme adenlyate cyclase 3 can be targeted to transform fat-storing white adipocytes into fat-burning brown adipocytes.

Picture: Genomtec S.A.

Dr Trevor Hawkins, entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Polish molecular diagnostic company Genomtec S.A.

Klineo team has grown since its inception in 2021. © Kineo SAS

Paris-based Klineo SAS has raised €2M to speed up access to clinical trials for oncology patients using an AI platform.
`

LG Draft "ball". © Locate Bio Ltd

University Nottingham spin out Locate Bio Ltd has added £9.2m venture financing led by Mercia Ventures and Business Growth Fund to its £16.2m raised before.

Electrochaea‘s scalable methanation system. © Electrochea GmbH

Archaeal Power-to-biomethan producer Electrochaea GmbH has sold a BioCat bioreactor to the Danish CCU  specialist Again A/S.

Structuren of Pub domain of RNF31. © RCBS protein data base

Oss-based oncology company Flindr Therapeutics BV has secured €20m  to advance it first-in-class RNF31 inhibitors, which destabilises E3 ubiquitin ligase.

Crystalline cellulose © Nordic Bioproducts Group

Finnish Nordic Bioproducts Group has opened a production facility to produce advanced cellulosic materials wit the start-up’s AaltoCell technology

Picture: © Future Insight e.V.

From July 10th to 11th, the multidisciplinary Curious2024 – Future Insight™️ Conference is bringing together some of the world’s brightest scientists, including several Nobel laureates, and the most accomplished innovators to present their work and explore the future of science and technology, solving the challenges of today and enabling the dreams of a better tomorrow.

Leiden-based Amarna Therapeutics welcomed Aurelia Caparrós as its new Chief Business Officer (CBO) in April.